MXPA03007141A - Procedimiento para la preparacion de un concentrado de ingredientes activos, y un concentrado de ingredientes activos. - Google Patents
Procedimiento para la preparacion de un concentrado de ingredientes activos, y un concentrado de ingredientes activos.Info
- Publication number
- MXPA03007141A MXPA03007141A MXPA03007141A MXPA03007141A MXPA03007141A MX PA03007141 A MXPA03007141 A MX PA03007141A MX PA03007141 A MXPA03007141 A MX PA03007141A MX PA03007141 A MXPA03007141 A MX PA03007141A MX PA03007141 A MXPA03007141 A MX PA03007141A
- Authority
- MX
- Mexico
- Prior art keywords
- active ingredient
- ingredient concentrate
- producing
- water
- concentrate
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 2
- 239000012141 concentrate Substances 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 229940087168 alpha tocopherol Drugs 0.000 abstract 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 abstract 1
- 235000019136 lipoic acid Nutrition 0.000 abstract 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 1
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 1
- 239000006014 omega-3 oil Substances 0.000 abstract 1
- 239000004550 soluble concentrate Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 229960002663 thioctic acid Drugs 0.000 abstract 1
- 229960000984 tocofersolan Drugs 0.000 abstract 1
- 239000002076 α-tocopherol Substances 0.000 abstract 1
- 235000004835 α-tocopherol Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10109708A DE10109708A1 (de) | 2001-02-11 | 2001-02-11 | Wasserlösliches Wirkstoffkonzentrat |
| DE10108614A DE10108614B4 (de) | 2001-02-22 | 2001-02-22 | Wasserlösliches Konzentrat eines stoffwechselbeeinflussenden Wirkstoffes |
| PCT/EP2002/001416 WO2002085328A2 (de) | 2001-02-11 | 2002-02-11 | Verfahren zur herstellung eines wirkstoffkonzentrats sowie wirkstoffkonzentrat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03007141A true MXPA03007141A (es) | 2003-11-18 |
Family
ID=26008603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03007141A MXPA03007141A (es) | 2001-02-11 | 2002-02-11 | Procedimiento para la preparacion de un concentrado de ingredientes activos, y un concentrado de ingredientes activos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040081670A1 (es) |
| EP (3) | EP1377273B1 (es) |
| JP (2) | JP2004531530A (es) |
| AT (2) | ATE381923T1 (es) |
| AU (1) | AU2002250914A1 (es) |
| CA (1) | CA2436273A1 (es) |
| DE (2) | DE50213362D1 (es) |
| ES (1) | ES2324400T3 (es) |
| MX (1) | MXPA03007141A (es) |
| WO (1) | WO2002085328A2 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040081670A1 (en) * | 2001-02-11 | 2004-04-29 | Dariush Behnam | Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| MXPA04002145A (es) | 2002-06-29 | 2005-03-07 | Aquanova Ger Solubilisate Tech | Concentrado de isoflavonas asi como procedimiento para su preparacion. |
| DE10306177A1 (de) * | 2003-02-13 | 2004-09-02 | Aquanova German Solubilisate Technologies (Agt) | Wirkstoffkonzentrate |
| DE20319249U1 (de) * | 2003-12-10 | 2004-12-30 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Lutein-Konzentrat |
| JP2008506725A (ja) | 2004-07-22 | 2008-03-06 | アクヴァノヴァ・ジャーマン・ソリュービリセイト・テクノロジーズ・（アーゲーテー）・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | エッセンシャルオイルおよび他の物質の可溶化産物 |
| WO2006018301A1 (de) * | 2004-08-18 | 2006-02-23 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Liponsäure-konzentrat |
| EP1814412A1 (en) * | 2004-09-27 | 2007-08-08 | Nestec S.A. | Skin care beverage composition |
| EP1904042A2 (de) * | 2005-07-08 | 2008-04-02 | Aquanova Ag | Wirkstoffextrakt-solubilisate |
| DE102006024911A1 (de) * | 2006-05-24 | 2007-11-29 | Aquanova Ag | Boswellinsäure-Konzentrat |
| JP2007016000A (ja) * | 2005-07-11 | 2007-01-25 | Taiyo Kagaku Co Ltd | チオクト酸含有組成物 |
| BRPI0708585B1 (pt) * | 2006-03-07 | 2017-02-21 | Aquanova Ag | solubilizado livre de agente de estabilização, processo para a preparação e uso do mesmo |
| ES2382576T3 (es) * | 2006-09-22 | 2012-06-11 | Mivital Ag | Emulsiones que contienen goma arábiga |
| CA2707010A1 (en) | 2007-12-14 | 2009-06-25 | Kazuhisa Sugimoto | .alpha.-lipoic acid nanoparticles and methods for preparing thereof |
| JP5951489B2 (ja) * | 2009-10-16 | 2016-07-13 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | 組成物 |
| AU2010308571B2 (en) | 2009-10-22 | 2016-10-13 | Tpc-Api Llc | Methods of making and using compositions comprising flavonoids |
| US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| EA032941B1 (ru) | 2010-03-12 | 2019-08-30 | БЕРГ ЭлЭлСи | ЛЕКАРСТВЕННЫЕ ФОРМЫ КОЭНЗИМА Q10 (CoQ10) ДЛЯ ВНУТРИВЕННОГО ВВЕДЕНИЯ И ИХ ПРИМЕНЕНИЕ |
| AU2011318580B2 (en) * | 2010-10-22 | 2016-01-07 | Technology Investments Lc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| CA2839270C (en) | 2011-06-17 | 2018-09-18 | Berg Llc | Inhalable liposomal pharmaceutical compositions |
| DE102012103767A1 (de) * | 2012-04-27 | 2013-10-31 | Chemische Fabrik Budenheim Kg | Antimikrobielles Mittel |
| DE202012012130U1 (de) * | 2012-12-19 | 2014-03-21 | Aquanova Ag | Curcuminsolubilisat |
| JP7063558B2 (ja) * | 2017-08-03 | 2022-05-09 | 花王株式会社 | 膜構造体の製造方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3052608A (en) * | 1959-05-07 | 1962-09-04 | Joseph J Hirsh | Lanolin transparent emulsions |
| US3390098A (en) * | 1964-06-08 | 1968-06-25 | Armour Pharma | Antioxidant composition |
| US4146499A (en) * | 1976-09-18 | 1979-03-27 | Rosano Henri L | Method for preparing microemulsions |
| DE3048000A1 (de) * | 1980-12-19 | 1982-07-15 | Basf Ag | Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung |
| JP2565513B2 (ja) * | 1987-09-25 | 1996-12-18 | 三省製薬株式会社 | メラニン生成抑制外用薬剤 |
| CA2010894A1 (en) * | 1989-02-28 | 1990-08-31 | Isamu Horikoshi | Method of forming a suspension and composition formed by said method |
| JPH03165833A (ja) * | 1989-02-28 | 1991-07-17 | Isamu Horikoshi | 新規懸濁化方法及びこの方法によって得られる組成物 |
| PT95826B (pt) * | 1989-11-09 | 1997-11-28 | Asta Medica Ag | Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico |
| DE4038385C2 (de) * | 1990-12-01 | 1998-09-17 | Hoyer Gmbh & Co Kg | Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit |
| US5569670A (en) * | 1992-06-05 | 1996-10-29 | Asta Medica Aktiengesellschaft | Combination medications containing alpha-lipoic acid and related |
| CH685325A5 (de) * | 1994-01-04 | 1995-06-15 | Marigen Sa | Ultramikroemulsionen aus spontan dispergierbaren Konzentraten mit schwer löslichen Carotinen. |
| EP0751988B1 (en) * | 1994-03-22 | 2000-02-09 | The Immune Response Corporation | Highly efficient production and isolation of viral particles |
| WO1997010814A1 (en) * | 1995-09-18 | 1997-03-27 | Vesifact Ag | Propofol nanodispersions |
| AU4807197A (en) * | 1996-10-03 | 1998-04-24 | Paul Bunn | Hydrophilic microparticles and methods to prepare same |
| DE19647352C2 (de) * | 1996-11-15 | 2000-06-29 | Aqua Nova Getraenketechnologie | Nicht alkoholisches Getränk mit einem Gehalt an Q 10 |
| JP4761093B2 (ja) * | 1997-12-10 | 2011-08-31 | シクロスポリン セラポイティクス リミテッド | オメガ−３脂肪酸油を含む医薬組成物 |
| US6251420B1 (en) * | 1998-01-28 | 2001-06-26 | Dusan Miljkovic | Isoflavanoid formulations for oral administration |
| JP3335307B2 (ja) * | 1998-03-19 | 2002-10-15 | 株式会社東芝 | ソルダーペースト及びハンダ接合形成用フラックス |
| JP2002513750A (ja) * | 1998-05-07 | 2002-05-14 | エラン コーポレーシヨン ピーエルシー | 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム |
| EP0956779A1 (de) * | 1998-05-11 | 1999-11-17 | Vesifact Ag | Nahrungsmittel, welche wasserunlösliche Komponenten enthalten |
| US6197340B1 (en) * | 1998-05-28 | 2001-03-06 | Medical Research Institute | Controlled release lipoic acid |
| AU7638300A (en) * | 1999-10-20 | 2001-04-30 | Vesifact Ag | Microemulsion preconcentrates and microemulsions |
| US6664287B2 (en) * | 2000-03-15 | 2003-12-16 | Bethesda Pharmaceuticals, Inc. | Antioxidants |
| DE10104847B4 (de) * | 2000-06-09 | 2006-12-21 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Tocopherol-Konzentrat und Verfahren zu seiner Herstellung |
| DE10103454A1 (de) * | 2000-12-29 | 2002-08-01 | Aquanova Getraenketechnologie | Wirkstoffkonzentrate sowie Verfahren zu ihrer Herstellung |
| US20040081670A1 (en) * | 2001-02-11 | 2004-04-29 | Dariush Behnam | Method for producing an active ingredient concentrate, and an active ingredient concentrate |
-
2002
- 2002-02-11 US US10/470,749 patent/US20040081670A1/en not_active Abandoned
- 2002-02-11 WO PCT/EP2002/001416 patent/WO2002085328A2/de not_active Ceased
- 2002-02-11 EP EP02719799A patent/EP1377273B1/de not_active Expired - Lifetime
- 2002-02-11 EP EP04010510A patent/EP1475083B1/de not_active Expired - Lifetime
- 2002-02-11 JP JP2002582902A patent/JP2004531530A/ja active Pending
- 2002-02-11 DE DE50213362T patent/DE50213362D1/de not_active Expired - Lifetime
- 2002-02-11 ES ES02719799T patent/ES2324400T3/es not_active Expired - Lifetime
- 2002-02-11 EP EP05027278A patent/EP1645267A3/de not_active Withdrawn
- 2002-02-11 CA CA002436273A patent/CA2436273A1/en not_active Abandoned
- 2002-02-11 AU AU2002250914A patent/AU2002250914A1/en not_active Abandoned
- 2002-02-11 MX MXPA03007141A patent/MXPA03007141A/es active IP Right Grant
- 2002-02-11 DE DE50211435T patent/DE50211435D1/de not_active Expired - Lifetime
- 2002-02-11 AT AT04010510T patent/ATE381923T1/de active
- 2002-02-11 AT AT02719799T patent/ATE425743T1/de active
-
2006
- 2006-04-19 JP JP2006115962A patent/JP2006241167A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE381923T1 (de) | 2008-01-15 |
| JP2004531530A (ja) | 2004-10-14 |
| DE50211435D1 (de) | 2008-02-07 |
| US20040081670A1 (en) | 2004-04-29 |
| ATE425743T1 (de) | 2009-04-15 |
| EP1475083B1 (de) | 2007-12-26 |
| WO2002085328A2 (de) | 2002-10-31 |
| EP1645267A2 (de) | 2006-04-12 |
| ES2324400T3 (es) | 2009-08-06 |
| HK1073994A1 (zh) | 2005-10-28 |
| JP2006241167A (ja) | 2006-09-14 |
| EP1377273A2 (de) | 2004-01-07 |
| WO2002085328A3 (de) | 2003-11-06 |
| AU2002250914A1 (en) | 2002-11-05 |
| EP1645267A3 (de) | 2007-10-10 |
| DE50213362D1 (de) | 2009-04-30 |
| EP1475083A1 (de) | 2004-11-10 |
| CA2436273A1 (en) | 2002-10-31 |
| EP1377273B1 (de) | 2009-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03007141A (es) | Procedimiento para la preparacion de un concentrado de ingredientes activos, y un concentrado de ingredientes activos. | |
| WO2002096374A3 (en) | Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives | |
| WO2003000343A3 (en) | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation | |
| ATE334663T1 (de) | Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe | |
| EP1374679A3 (en) | Sterilizing composition and method for sterilizing using the same | |
| WO2002011696A3 (en) | Active tissue augmentation materials and method | |
| DE59504589D1 (de) | Wäschenachbehandlungsmittel | |
| DK0948965T3 (da) | Stabile medicinske præparater indeholdende 4,5-epoxymorphinanderivater | |
| ITMI991860A0 (it) | Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici e pr ocedimento per la loro preparazione | |
| YU84703A (sh) | Oralni rastvor aripiprazola | |
| WO2003049689A3 (en) | Isoflavone composition for oral delivery | |
| GB2341801B (en) | Formulation | |
| FR2766368B1 (fr) | Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres | |
| KR100260061B1 (en) | Vitamin e drop | |
| HRP20020298B1 (hr) | Farmaceutske otopine levosimendana | |
| AU1848901A (en) | A stable aqua formulation of interferon, the preparation method and the uses thereof | |
| ES2105219T3 (es) | Una composicion que contiene hierro para la prevencion de la anemia y un metodo para producir dicha composicion. | |
| HUP9901887A2 (hu) | HIV-proteáz inhibitort és vízoldékony E-vitamin származékokat tartalmazó gyógyászati készítmények | |
| AR032121A1 (es) | Formulacion agroquimica. | |
| WO2001030331A3 (en) | Therapeutic compositions including protein kinase c inhibitors | |
| AU2002218337A1 (en) | Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives | |
| EP0806421A4 (en) | DERIVATIVES OF CHINOLINE CARBONIC ACID | |
| WO2001024803A3 (en) | Pharmaceutical compositions containing copper, salicylic acid and vitamines c | |
| EP0775440A4 (en) | CHEMICAL PREPARATION FOR AGRICULTURAL USE AND PROCESS FOR PRODUCING THE SAME | |
| DE69722525D1 (de) | Auslöser für den bluteinsatz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| HC | Change of company name or juridical status |